CA2118713A1 - Simultaneous drug testing and fingerprinting assay - Google Patents

Simultaneous drug testing and fingerprinting assay

Info

Publication number
CA2118713A1
CA2118713A1 CA002118713A CA2118713A CA2118713A1 CA 2118713 A1 CA2118713 A1 CA 2118713A1 CA 002118713 A CA002118713 A CA 002118713A CA 2118713 A CA2118713 A CA 2118713A CA 2118713 A1 CA2118713 A1 CA 2118713A1
Authority
CA
Canada
Prior art keywords
drug testing
simultaneous drug
assay device
pattern
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002118713A
Other languages
French (fr)
Other versions
CA2118713C (en
Inventor
Raouf A. Guirguis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
La Mina Ltd
Original Assignee
Raouf A. Guirguis
La Mina, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raouf A. Guirguis, La Mina, Ltd. filed Critical Raouf A. Guirguis
Publication of CA2118713A1 publication Critical patent/CA2118713A1/en
Application granted granted Critical
Publication of CA2118713C publication Critical patent/CA2118713C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/117—Identification of persons
    • A61B5/1171—Identification of persons based on the shapes or appearances of their bodies or parts thereof
    • A61B5/1172—Identification of persons based on the shapes or appearances of their bodies or parts thereof using fingerprinting
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/0051—Devices for taking samples of body liquids for taking saliva or sputum samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B2010/0009—Testing for drug or alcohol abuse
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/816—Alkaloids, amphetamines, and barbiturates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/901—Drugs of abuse, e.g. narcotics, amphetamine

Abstract

An assay device and method, which allow for the determination of the presence or absence of at least one analyte in a test sample, while providing specific identification of the test subject are disclosed. The assay device includes a reaction zone made up of separate reaction zones for detecting one or more specific analytes located within a control area and a control zone for providing a pattern for identifying the test subject, the preferred pattern being a fingerprint. In the preferred embodiment of the invention, the reaction zone and the control zone include at least one member of a ligand/receptor pair.
CA002118713A 1991-09-13 1992-09-14 Simultaneous drug testing and fingerprinting assay Expired - Fee Related CA2118713C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/759,922 1991-09-13
US07/759,922 US5244815A (en) 1990-01-19 1991-09-13 Fingerprint test pad and method for fingerprinting using particle based immunoassay
PCT/US1992/007785 WO1993006486A1 (en) 1991-09-13 1992-09-14 Simultaneous drug testing and fingerprinting assay

Publications (2)

Publication Number Publication Date
CA2118713A1 true CA2118713A1 (en) 1993-04-01
CA2118713C CA2118713C (en) 2006-08-22

Family

ID=25057473

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002118713A Expired - Fee Related CA2118713C (en) 1991-09-13 1992-09-14 Simultaneous drug testing and fingerprinting assay

Country Status (8)

Country Link
US (1) US5244815A (en)
EP (1) EP0643834B1 (en)
JP (1) JPH07503536A (en)
AT (1) ATE195587T1 (en)
AU (2) AU2664392A (en)
CA (1) CA2118713C (en)
DE (1) DE69231362T2 (en)
WO (1) WO1993006486A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352863B1 (en) * 1990-01-19 2002-03-05 La Mina, Inc. Assay device
KR100314101B1 (en) * 1993-09-17 2001-12-28 라오우프에이.기르구이스 Analysis device
DE69432424T2 (en) * 1993-10-21 2004-03-18 Abbott Laboratories, Abbott Park DEVICE AND METHOD FOR DETECTING CELLIGANDS
ES2325393T3 (en) * 1993-10-28 2009-09-03 Houston Advanced Research Center POROUS FLOW EQUIPMENT THROUGH MICROFABRICATED FOR THE DIFFERENTIATED DETECTION OF UNION REACTIONS.
US6893816B1 (en) 1993-10-28 2005-05-17 Houston Advanced Research Center Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions
EP0675362B1 (en) * 1994-03-30 2000-09-27 Johnson & Johnson Clinical Diagnostics, Inc. Minimizing interferences in chemiluminescent thin-film immunoassays
DE19502375C2 (en) * 1995-01-26 2000-06-21 Denzel Klaus Narcotics detection system
US5874216A (en) 1996-02-23 1999-02-23 Ensys Environmental Products, Inc. Indirect label assay device for detecting small molecules and method of use thereof
CA2254962A1 (en) * 1996-05-13 1997-11-20 James E. Beecham Method and apparatus for ascertaining medical conditions
US5876926A (en) * 1996-07-23 1999-03-02 Beecham; James E. Method, apparatus and system for verification of human medical data
DE19640121B4 (en) * 1996-09-28 2007-04-26 Dade Behring Marburg Gmbh Method for determining a time-dependent variable to be measured
US5968746A (en) 1997-11-26 1999-10-19 Schneider; David R. Method and apparatus for preserving human saliva for testing
GB2342443A (en) * 1998-10-02 2000-04-12 Abp Diagnostics Limited Immunoassay device
US6699722B2 (en) 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
US6663831B2 (en) 2001-04-04 2003-12-16 Forefront Diagnostics, Inc. “One-device” system for testing constituents in fluids
DE60238699D1 (en) * 2001-09-17 2011-02-03 Phadia Ab MULTIPLE ANALYTASSAY DEVICE WITH MULTI-SPOT DETECTION ZONE
DE10206396A1 (en) * 2002-02-15 2003-02-06 Siemens Ag New biochip, for recording patient's medical data, together with the results of tests on a biological sample, comprises establishing biometric key to be compared with the patient's electronic record for a match
US20040087874A1 (en) * 2002-10-28 2004-05-06 David Schneider Saliva collection system
US20050135964A1 (en) * 2003-12-22 2005-06-23 Ulrich Sieben Carrier medium for analyzing a substance
US20060057728A1 (en) * 2004-09-14 2006-03-16 Michael Katz Method to prevent urine specimen and other specimen substitution in substance use screening
GB0605965D0 (en) * 2006-03-24 2006-05-03 Univ East Anglia Fluorescence based detection of substances
US7879623B2 (en) 2006-03-31 2011-02-01 Guirguis Raouf A Integrated device for analyte, testing, confirmation, and donor identity verification
US8940527B2 (en) * 2006-03-31 2015-01-27 Lamina Equities Corp. Integrated device for analyte testing, confirmation, and donor identity verification
US11906512B2 (en) 2006-03-31 2024-02-20 Zeus Diagnostics, LLC Integrated device for analyte testing, confirmation, and donor identity verification
US7741103B2 (en) * 2006-03-31 2010-06-22 Guirguis Raouf A Integrated screening and confirmation device
GB2528654B (en) * 2014-07-24 2017-01-04 Intelligent Fingerprinting Ltd Drug dispenser assembly
US10564155B2 (en) 2017-01-27 2020-02-18 Raouf A Guirguis Dual swab fluid sample collection for split sample testing and fingerprint identification device
GB2560967A (en) * 2017-03-30 2018-10-03 Intelligent Fingerprinting Ltd Technique for developing skin-prints on an absorbent substrate
GB2569396B (en) * 2017-12-18 2020-08-12 Intelligent Fingerprinting Ltd A method and apparatus for use in the analysis of a skin-print
GB2570944B (en) * 2018-02-13 2020-08-19 Intelligent Fingerprinting Ltd A method of analysing a skin-print
GB2577237B (en) * 2018-05-21 2020-09-30 Intelligent Fingerprinting Ltd Skinprint analysis method and apparatus
US11730458B2 (en) 2019-02-14 2023-08-22 Marshall Venture Partners LLC Systems and methods for fluid sample collection and testing
US11724255B2 (en) 2019-02-14 2023-08-15 Marshall Venture Partners LLC Systems and methods for fluid sample collection and testing
WO2022073099A1 (en) * 2020-10-06 2022-04-14 Green Belting Industries Ltd. Metalized nano coated swab for trace detection

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3419000A (en) * 1965-10-04 1968-12-31 Robert E. Phillips Card for medical testing and method of making the same
US4632901A (en) * 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
CA1272127A (en) * 1985-04-04 1990-07-31 Hybritech Incorporated Solid phase system for use in ligand-receptor assays
US5009919A (en) * 1986-12-05 1991-04-23 Vassiliades Anthony E Finger-printing systems & method
US4774192A (en) * 1987-01-28 1988-09-27 Technimed Corporation A dry reagent delivery system with membrane having porosity gradient
US4810630A (en) * 1987-03-30 1989-03-07 E. I. Du Pont De Nemours And Company Use of polyoxyethylene ethers to improve the performance of immunoassays employing peroxidase conjugates
US4883764A (en) * 1987-07-20 1989-11-28 Kloepfer Mary A Blood test strip
US4853335A (en) * 1987-09-28 1989-08-01 Olsen Duane A Colloidal gold particle concentration immunoassay
US4963325A (en) * 1988-05-06 1990-10-16 Hygeia Sciences, Inc. Swab expressor immunoassay device
US5079172A (en) * 1988-11-04 1992-01-07 Board Of Trustees Operating Michigan State University Method for detecting the presence of antibodies using gold-labeled antibodies and test kit
DE69127383T2 (en) * 1990-01-19 1998-03-05 Mina Ltd Device and method for examining blood and for fingerprint identification

Also Published As

Publication number Publication date
US5244815A (en) 1993-09-14
AU2664392A (en) 1993-04-27
DE69231362T2 (en) 2000-12-28
CA2118713C (en) 2006-08-22
EP0643834A4 (en) 1994-12-01
AU1493197A (en) 1997-05-22
JPH07503536A (en) 1995-04-13
ATE195587T1 (en) 2000-09-15
EP0643834B1 (en) 2000-08-16
WO1993006486A1 (en) 1993-04-01
DE69231362D1 (en) 2000-09-21
EP0643834A1 (en) 1995-03-22

Similar Documents

Publication Publication Date Title
CA2118713A1 (en) Simultaneous drug testing and fingerprinting assay
DK140690D0 (en) APPARATUS FOR ANALYTICAL PROVISIONS
ATE191566T1 (en) CAPTIVE PARTICLE REAGENT TEST APPARATUS
FI973802A0 (en) Sensor system for detecting analytes in fluids
DE69532133D1 (en) DEVICES AND METHODS THAT USE STRUCTURAL FIELDS TO BIND ANALYTES
AU633874B2 (en) Threshold ligand-receptor assay
ES2038381T3 (en) DEVICE FOR THE CONDUCT OF BIOLOGICAL ANALYSIS BY IMMUNO-ENZYMATIC DETECTION OF ANTIBODIES OR ANTIGENS IN SERUM.
WO2000008466A3 (en) Analytical test device and method
EP1992951A3 (en) Method and apparatus for performing a lateral flow assay
EP2284536A3 (en) Multi-array, multi-specific electrochemiluminescence testing
BR9916449A (en) Test device, methods for determining a disease condition or a disorder or a propensity for the development of a disease condition or a disorder and for treating cancer or a propensity for the development of cancer in a human animal or non-human, use of an array of molecules, and, method for identifying a mimetic protein in a chemical or biological sample
GB9804083D0 (en) Immunoassays
EP0806663A3 (en) Apparatus and method for determination of non-hemolyzed levels of occult blood in urine
AU9066998A (en) Use of check surfaces for identifying disturbing samples in a detection procedure
EP0791176A4 (en) Detection device and method
WO2002004946A3 (en) Methods for identifying combinations of drugs
EP0214520A3 (en) Immunoassay for detection of ras encoded protein
DE69529691D1 (en) DIFFERENTIATED TIMING PROCEDURE FOR DETECTING MULTIPLE ANALYTES IN A TEST SAMPLE
ATE114822T1 (en) REAGENTS FOR THE DETECTION OF BILIRUBIN IN URINE.
DE69523492T2 (en) Immunoassay reagents, test kits and procedures
WO2003012026A8 (en) Apparatus and method for determining the onset and presence of sepsis conditions
ATE382709T1 (en) HOMOGENEOUS GENE PROBE TEST WITH AN AGAINST LABEL RECEPTOR
ES2070211T3 (en) METHOD FOR THE TESTING OF ISOENZYMES.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed